Programs
Who It Is For
Getting Started
Cost and Coverage
Service Areas
Get in Touch
Resources
GLP-1 medication
Names, approved uses and treatment formats can make weight loss prescriptions confusing. This guide helps Miami adults identify what to check when reading about semaglutide, tirzepatide and related products. Miami Weight Loss is an information and inquiry website. A licensed prescriber must evaluate whether a medicine fits your health needs; this site does not prescribe or supply it.
Two molecules
The active ingredient identifies the medicine, while its brand name identifies a particular product. For semaglutide treatment in Miami, that distinction includes how the medicine is taken and what it is approved to treat. Wegovy includes both injection and tablet formulations for weight management in eligible adults. Products sharing an ingredient can still have different indications and instructions, so they should not be treated as interchangeable purchases.
The same care is needed when reading about tirzepatide weight loss treatment. Zepbound and Mounjaro contain tirzepatide, but their labels describe different approved uses. A prescriber considers the actual product alongside medical history, other treatments and preferences. Information about oral GLP-1 tablets can help you raise practical questions about daily instructions, rather than assuming that every tablet or injection follows the same routine.
Before committing to a prescription, establish the product name, formulation, pharmacy and instructions you would receive. Questions about weight loss medication eligibility should include why the clinician recommends that product and what follow-up is needed. Ask about alternatives if it is unsuitable or unaffordable. This overview introduces the medication pages below; it is not an exhaustive list of prescription options or a recommendation to use a particular medicine.
Getting a prescription
BMI, conditions, personal and family history, and everything else you take. Some histories rule a GLP-1 out entirely, and that is decided here.
Semaglutide or tirzepatide, injectable or tablet. Availability and your drug plan are part of the decision, not an afterthought.
Every GLP-1 starts low. The starting dose is not a treatment dose, it is there to let your body adjust.
The dose steps up on a schedule, and only if the current step is tolerated. Rushing this is what causes most of the misery people describe.
Medications
Two molecules, four brands and one tablet. The same clinician review applies to all of them.
The GLP-1 molecule behind Ozempic and Wegovy, and how it is used for weight.
Learn moreThe dual GLP-1 and GIP molecule behind Mounjaro and Zepbound.
Learn moreSemaglutide approved for type 2 diabetes, and what that means for weight use.
Learn moreSemaglutide approved specifically for weight management.
Learn moreTirzepatide approved for type 2 diabetes.
Learn moreTirzepatide approved specifically for weight management.
Learn moreThe daily tablet option, and who it suits better than an injection.
Learn moreWhat is common, what is serious and what to do about each.
Learn moreCommon questions
Brand names, daily routines, overlapping medicines, compounded preparations and insurance decisions.
I had the brand names muddled completely. Ten minutes of explanation and I finally understood what I was actually being prescribed and why.
Switched molecules after the first one did not agree with me. That was treated as a normal adjustment rather than a failure.
The tablet suited me better than a weekly injection. The instructions about timing and food were stricter than I expected but they were explained clearly.
They checked what my cardiologist had me on before writing anything. Two things needed spacing out.
From the blog
Next step
Suitability depends on your conditions and what you already take. The free check is where that gets looked at, before any product is discussed.
Licensed clinicians · Eligibility reviewed before any prescription · Virtual appointments